loader

World Tenders & Procurement Opportunities

Search
Advanced Search

Conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8/130c Paragraph 1 SGB V for medicinal products containing the active ingredient levothyroxine sodium (H03AA01) within the framework of a so-called open-house model. - 675443

World Biggest Tenders Source

This tender with title Conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8/130c Paragraph 1 SGB V for medicinal products containing the active ingredient levothyroxine sodium (H03AA01) within the framework of a so-called open-house model. - 675443 has been published on Bidding Source portal dated 12 Nov 2024 for the country of Germany. It has been categorized on Pharmaceutical products. For similar tenders you can see tenders mentioned below of this page.

General Information

Germany

Conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8/130c Paragraph 1 SGB V for medicinal products containing the active ingredient levothyroxine sodium (H03AA01) within the framework of a so-called open-house model. - 675443
Invitation for Bids
Germany
12 Nov 2024
31 Oct 2026
English
Pharmaceutical products

For viewing full details of tenders, you should Log in to your account. If not registered yet, Please Register Now

Or Request a call back now and one of our representatives will contact you. Contact us

Similar Tenders

Pharmaceutical products – Patent_80.3 - 682813 Germany Conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8 SGB V for the active ingredients mentioned with the possibility of conclusion within the framework of the so-called open house procedure. - 676935 Germany Conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8/130c Paragraph 1 SGB V for medicinal products containing the active ingredient cetrorelix (H01CC02) within the framework of a so-called open-house model. - 676201 Germany Conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8/130c Paragraph 1 SGB V for medicinal products containing the active ingredient fluorouracil, combinations (D11AF55) within the framework of a so-called open-house model. - 676991 Germany Pharmaceutical products – Patent_80.1 - 681316 Germany Conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8 SGB V for the active ingredients mentioned with the possibility of conclusion within the framework of the so-called open house procedure. - 683215 Germany Pharmaceutical products – Patent_80.2 - 681458 Germany Conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8 SGB V for the active ingredients mentioned with the possibility of conclusion within the framework of the so-called open house procedure. - 674329 Germany Conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8/130c Paragraph 1 SGB V for medicinal products containing the active ingredient guselkumab (L04AC16) within the framework of a so-called open-house model. - 674374 Germany Conclusion of non-exclusive discount agreements pursuant to Section 130 a Paragraph 8 SGB V with the active ingredient meloxicam - 666962 Germany
Pharmaceutical products Tenders
Germany Tenders
Europe Tenders
Tenders
No. 12, 1 st floor, Block B2, EGS Business Park, World Trade Center, Bakirkoy - Istanbul - Turkey
info@biddingsource.com
24 X 7 online support
TOP
For viewing latest tenders published for your business in all over the World: Sign in Join free
For accessing full details of Tenders, Kindly choose the Plan that works for you: View Subscription Plans